drug: duloxetine |
|
|
| Clinical class | antidepressant |
| Action | selective serotonin norepinephrine reuptake inhibitor |
| Chemical class | thiophenepropanamine |
| CSA schedule | none |
| DEA number | none |
| Routes of administration | oral |
| Associated with (substance-related)
|
disorders: none |
| Availability | prescription |
U.S. Preparations:
- Cymbalta® (Lilly)
FDA
approved for treatment of:
8.3.2004 Major Depressive Disorder
9.3.2004 pain associated with diabetic peripheral neuropathy
2.23.2007 Generalized Anxiety Disorder
6.13.2008 fibromyalgia
U.S. Prescribing information